May 2nd, 2017 Mehul J Desai, M.D., M.P.H joins SmartImplantSystems’ Clinical Advisory Board
Mehul J. Desai, MD, MPH is board certified in Pain Medicine and Physical Medicine & Rehabilitation. Dr. Desai completed his residency in Physical Medicine & Rehabilitation at the Georgetown University Hospital. During residency he spent 6 months completing a research fellowship at the National Institutes of Health conducting groundbreaking research into mechanisms of muscle pain. Upon completion of residency he went on to a fellowship in Pain Medicine at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania in the Department of Anesthesiology. His clinical interests include musculoskeletal disease (tendon injuries & osteoarthritis), discogenic pain and intradiscal therapies including biologics, neuromodulation; specifically spinal cord stimulation and targeted drug delivery, complex spinal conditions, pelvic pain, outcomes-based research and healthcare economics. He is committed to the use of cutting-edge technologies in the treatment of musculoskeletal disease and pain.
Dr. Desai is the Founder and President of the International Spine, Pain & Performance Center, a collaborative, interdisciplinary practice located in Washington, DC. Formerly, Dr. Desai was Assistant Professor, Department of Anesthesiology & Critical Care Medicine and of Neurosurgery at the George Washington University Medical Center and served as the Director, Pain Medicine and Non-Operative Spine Services of the GW Spine & Pain Center and Director, Sibley Pain Center at the Sibley Memorial Hospital. Furthermore, he was Director, Outpatient Rehabilitation Center at the George Washington University Hospital. He also served as a clerkship director for Physical Medicine & Rehabilitation at the George Washington University, School of Medicine and mentored both residents in Anesthesiology and Physical Medicine & Rehabilitation. He remains involved with resident and medical student education, serving as Clinical Assistant Professor at the George Washington University.
Dr. Desai maintains an avid interest in research, serving as the principle investigator on multiple ongoing clinical trials including studies on ablation and spinal cord stimulation. He serves as a member of the steering committee of the largest clinical trial investigating the efficacy of spinal cord stimulation in chronic low back pain following spine surgery. Dr. Desai has published articles in Pain Practice, Neuromodulation, Pain Physician, Archives of Physical Medicine and Rehabilitation; Pain Medicine and the Journal of the American Osteopathic Association. He has authored multiple book chapters and is currently completing his second textbook.
Dr. Desai presents annually at many international and national pain medicine meetings, traveling to Hong Kong, Dubai, China, Italy, and across the United States last year. Furthermore, he serves as a peer educator; hosting physician visits and teaching advanced pain medicine techniques to physicians both nationally and globally. Dr. Desai currently serves as a Leadership Fellow for the American Academy of Physical Medicine & Rehabilitation and the 2016 Legislative Fellow for the North American Neuromodulation Society.
April 24th, 2017 - Dr. Christopher Von Jako joins the Board of SmartImplantSystems
Dr. Christopher Von Jako, also known as Chris, Ph.D., has been Chief Executive Officer and President at NinePoint Medical, Inc, since December 04, 2014. Dr. Von Jako served as Chief Executive Officer and President of NeuroTherm, Inc. since May 2013. Dr. Von Jako has over 20 years of leadership success and experience in the global medical device market with a specific expertise in minimal invasive surgery. He has spent the past 25 years focusing on the development and commercialization of image-guided techniques to improve patient experience and outcomes. Since 2010 until he assisted in the divesture in 2013, Dr. Von Jako was the President of ActiViews, Ltd., a privately held high technical medical device company, which developed and marketed minimally invasive tools for Interventional Radiology. Previously, he served as Vice President of Marketing for the NeuroScience division at Integra LifeSciences from 2006 to 2010. Dr. Von Jako served in senior executive roles of progressive responsibility with Integra LifeSciences, Covidien, Medtronic, and Radionics. He served as General Manager of Integra Burlington MA, Inc. He joined Integra as part of his successful divestiture of the Radionics business unit from Covidien, where Dr. Von Jako was the General Manager from 2003 to 2006. Prior to this, he also worked as a Group Director at Medtronic Navigation after successfully assisting in the orchestration of a strategic collaboration with Odin Medical Technologies, where he was the General Manager and Executive Vice President. Dr. Von Jako began his career with Radionics, where he held various leadership positions including Director of International Sales and Marketing, Director of Worldwide Neurosurgical Sales, and Director of European Operations. Dr. Von Jako earned a Doctor of Philosophy degree in Biomedical Sciences from the University of Pécs Medical School (Pécs, Hungary), a Master of Science degree in Radiological Sciences and Technology from the department of Nuclear Engineering from the Massachusetts Institute of Technology (Cambridge, Massachusetts), and a double Bachelor of Science degree in Physics and Mathematics from Bates College (Lewiston, Maine).
Minneapolis MN, January 10th, 2017 – SmartImlplantSystems Inc. Issued Patents on Smart Spinal Technology
The USPTO has recently awarded two patents to SmartImplantSystems. In addition to these two patents, there are also published patents; as well as, fresh patents being filed by the company. The patents are the culmination of several years of work by spinal surgeons, engineers and interventional pain specialists. Dr. Nazmi Peyman is the lead author and inventor of the company’s technology.
January 30, 2017- SmarImplantSystems Inc. gets certified for the MN Angel Tax Credit.
SmartImplantSystems gets certified for the Minnesota Angel Tax Credit program. Minnesota's Angel Tax Credit provides a 25-percent credit to investors or investment funds that put money into startup companies focused on high technology, new proprietary technology, or a new proprietary product, process or service in specified fields. SmartImplantSystems is in the process of raising funds for its smart spine systems and has generated a lot of interest from investors
Feb 1st -2017 -Dr. Dennis Rivet joins SmartImplantSystems’ Scientific Advisory Board
Dr. Dennis Rivet is a board-certified neurosurgeon and an Associate Professor of Neurological Surgery at Virginia Commonwealth University. He is trained in both the open and endovascular treatment of complex cerebrovascular lesions, including aneurysms, arteriovenous malformations (AVMs), and interventional ischemic stroke therapies. As a fellowship-trained endovascular neurosurgeon, Dr. Rivet performs the most innovative surgical techniques, including minimally invasive treatments of the spectrum of intracranial vascular pathologies. His clinical practice also includes surgical treatment of benign and malignant spinal and cranial pathologies such as traumatic brain injury, spinal cord injury, and brain tumors. Dr. Rivet earned a Bachelor of Science degree in chemistry at the United States Naval Academy in Annapolis, Maryland, graduating with a Secretary of the Navy Distinguished Graduate Award (top 3% of class). He then received his Doctor of Medicine degree from Dartmouth Medical School
An active researcher in his field, Dr. Rivet has published extensively in the clinical, basic scientific, and humanistic realm. He has lectured extensively throughout North America and internationally on a variety of neuroscience topics. Currently, his research interests focus on neuroprotective strategies to prevent cerebral ischemia, endovascular device development, and methods to enhance radiation safety. He is the holder of more than 180 U.S. and international patents and has advised and consulted for medical technology companies in the U.S. and abroad.
During medical school, he took a leave of absence to complete a Howard Hughes Medical Institute Research Scholarship at the National Institutes of Health in Bethesda, Maryland followed by a National Science Foundation Fellowship at the National Cancer Center in Tokyo, Japan. He then went on to complete a residency in Neurological Surgery at Washington University in St. Louis, Missouri. Following residency, Dr. Rivet completed advanced fellowship training in Endovascular Surgical Neuroradiology at the Mallinckrodt Institute of Radiology in St. Louis, Missouri. Prior to his appointment at Virginia Commonwealth University, Dr. Rivet served on active duty in the U.S. Navy, including multiple overseas tours in Japan, Haiti, Afghanistan, Vietnam, and other locations.